In the typical adenoma–carcinoma sequence, colorectal cancers (CRCs) develop through the accumulation of mutations in several signaling pathways, including WNT, RAS, p53, DCC, and transforming growth factor-β (TGF-β) genes [31,32,33]. This evidence concerns the gene TP53 and carcinoma.